CD200R1 and hepatocellular carcinoma: Anti-CD200R1 monoclonal Ab inhibits tumor volume in mice inoculated with murine Hepa1–6 cells, suggesting that the CD200–CD200R pathway is involved in HCC tumor growth [145].